Shanghai Junshi Biosciences Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-983.00
-1,433.00
-2,686.00
-3,030.00
-658.00
-1,875.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
-575.00
-72.00
788.00
-33.00
75.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-518.00
-1,496.00
-2,098.00
-1,997.00
-690.00
-1,613.00
Cash Flow from Investing Activities
-1,758.00
-1,024.00
-1,144.00
-344.00
-1,271.00
-854.00
Cash Flow from Financing Activities
2,417.00
1,107.00
783.00
5,132.00
2,134.00
4,959.00
Net Cash Inflow / Outflow
116.00
-1,400.00
-2,451.00
2,898.00
144.00
2,439.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-23.00
13.00
8.00
107.00
-27.00
-51.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Junshi Biosciences Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-983.849140770664
1127.62207024835
-2,110.00
-187.25%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.25765012230716
-1096.26089560391
1,092.00
99.61%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-518.558835681885
110.26014366348
-628.00
-570.30%
Cash Flow from Investing Activities
-1758.59169387777
1062.88198038857
-2,820.00
-265.46%
Cash Flow from Financing Activities
2417.08346410736
291.389494568434
2,126.00
729.50%
Net Cash Inflow / Outflow
116.391699857736
1499.51410089889
-1,383.00
-92.24%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-23.5412346899721
34.9824822784052
-57.00
-167.29%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 65.35% vs 28.69% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-518.56
-1,496.50
65.35%






